Blog

Amanda Lund: IFN as a metabolic switch to prune tumor-associated lymphangiogenesis

Amanda Lund and Triantafyllia Karakousi

Dec 9, 2024, 15:08

Amanda Lund: IFN as a metabolic switch to prune tumor-associated lymphangiogenesis

“Excited to share our latest by Triantafyllia Karakousi where we find that IFNg acts as a metabolic switch to prune tumor-associated lymphangiogenesis and unlink immune surveillance and metastasis.”

IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma

Authors: Triantafyllia Karakousi, Vanessa Cristaldi, Maria Luiza Lopes de Oliveira, Luiz Henrique Medeiros Geraldo, Tania J. González-Robles, Gabrielle da Silva, Alec P. Breazeale, Joel Encarnacion-Rosado, Joanna Pozniak, Alec C. Kimmelman, Kelly V. Ruggles, J. Chris Marine, Navdeep S. Chandel, Amanda W. Lund

Alec C. Kimmelman Alec P. Breazeale Amanda W. Lund Gabrielle da Silva J. Chris Marine Joanna Poźniak Joel Encarnacion-Rosado Kelly V. Ruggles Luiz Henrique Medeiros Geraldo Maria Luiza Lopes de Oliveira Navdeep S. Chandel Tania J. González-Robles Triantafyllia Karakousi Vanessa Cristaldi

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology